Posted by Hugo Ottolenghi
February 4th, 2010
To understand why Sen. John McCain introduced a bill on dietary supplements, read the press releases. The legislation announced Feb. 3 addresses public safety, but mostly it’s about the reputation and revenue of professional and Olympic sports.
The evidence: McCain says in the release that “a little over a year ago the NFL suspended six players, [...]
Posted by Hugo Ottolenghi
January 8th, 2010
Marketers of nutritional supplements often complain that they do not know what the FDA wants. Even after the agency sends a warning letter about misleading claims and advertising, its staff does not explain what would fall within the rules. That’s the reality; the FDA will tell you what’s wrong, not what’s right.
Through warning letters, the [...]
Posted by Joel Rothman
January 3rd, 2010
2009 was an incredible year for the dietary supplement industry. While the rest of American business floundered amidst the depths of a recession, the dietary supplement business thrived. Americans concerned about maintaining their good health stocked up on supplements by the shopping cartful.
In a year when initial public offerings and acquisitions were almost unheard of, [...]
Posted by Hugo Ottolenghi
November 28th, 2009
David Frum could have lowered his rhetorical blood pressure in his CNN.com guest commentary on the evils of dietary supplement marketing by reading the FTC regulations that go into effect on Tuesday. His column then would have begun: The party is over Dec. 1.
Posted by Hugo Ottolenghi
November 22nd, 2009
News reports bring into question the efficacy and safety of some vitamins. However, there is an even greater threat from a product with no proven side effects and a very low price.
Posted by Hugo Ottolenghi
November 16th, 2009
Two days of hearings before the FDA about search-based advertising for drugs produced one possible solution: fixed warnings for products. Google has proposed that its AdWords could include a hyperlinked line that warns consumers about the potential dangers of a drug.